The Scientist - Home

Non-opioid, psychoactive compounds could offer relief for patients experiencing long-term pain and psychiatric conditions.

For years, no one knew what caused toxic epidermal necrolysis. Deep visual proteomics has now identified not only the cause, but a strong candidate for a cure. 

Researchers hope imaging-based mass spectrometry can be a clinical diagnostic tool for cancer.

Wildfire smoke can leave behind an ashy taste in wine called smoke taint. Bacteria that live on grapevines could degrade the main chemical behind this flavor.

The accuracy of non-invasive blood and stool-based tests for colorectal cancer is improving, but experts say it’s too soon to drop colonoscopies altogether.

This postdoc’s fascination with invisible forces grew into research that connects atmospheric physics with agriculture and food security.

These “zombie” cells are damaged yet refuse to die. Instead, they linger in the body, infect healthy cells, and can contribute to age-related decline.

Bats pollinate plants and control insects but also transmit diseases to humans. Researchers investigate ways to prevent viral spread.

With a passion for systems biology and multi-omics integration, this postdoc is turning datasets into narratives that uncover hidden mechanisms of disease.

Gene expression snapshots paint an incomplete picture of development. By tracking cell shape changes in live tissues, scientists may fill in the missing pieces.

Profiles of more than 2,500 people’s gut microbiomes revealed that the longer people took certain drugs, the larger the effect on their microbiome.

Twenty years into the Psychedelic Renaissance, neuroscientists still struggle to understand how psychedelics work and how to rectify misconceptions about these drugs.